Pith. sign in

REVIEW 4 major objections 5 minor 75 references

VetScore: Risk-Weighted Fact Verification for Veterinary Long-Form QA with Citations

T0 review · 4 major / 5 minor · reviewed 2026-08-05 · deepseek-v4-flash

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗ Review JSON

Pith's one-line read VetScore claims an automated, risk-weighted faithfulness score can match veterinary expert judgments on cited long-form answers, reaching a 0.783 correlation with small judge models.

desk verdict Solid risk-weighted verification pipeline for veterinary QA with a genuinely useful dataset, but the combined-score headline leans on a hand-set weight shared with the human gold. read the letter →

arxiv 2608.03675 v1 pith:IYD6OFGJ submitted 2026-08-04 cs.CL

Ivan Kartáč , Jan Tovarys , Mateusz Lango , Ondřej Dušek This is my paper · ORCID
classification cs.CL
keywords factverificationrisk-weightedevaluationharmpotentialveterinarymedicinelong-formquestionansweringcitationfaithfulnessLLM-as-judgedecompose-then-verify
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

VetScore is an evaluation method for veterinary long-form question-answering systems that produce answers with citations. Its central claim is that the faithfulness of an answer to its cited excerpts can be scored automatically in a way that weights each claim by how much harm a wrong claim could cause, and that this score tracks the judgments of veterinary experts. On a new expert-annotated meta-evaluation dataset of 1,200 segments and 4,986 claims, the method reaches rank correlations up to 0.783 for fact verification, 0.763 for harm potential, and 0.740 for the combined risk-adjusted score, with the open-weight Gemma 4 31B model close behind at 0.724, 0.721, and 0.677. The claim matters because high-stakes medical answers carry unequal risk—a wrong drug dose is more dangerous than a wrong study year—and existing fact-verification metrics treat every claim equally.

What carries the argument

The load-bearing object is the risk-adjusted combined score S(Y')=1−p_global(Y'), where p_global is the harm-weighted penalty: each claim contributes w_i^p(1−v_i) to the numerator and Σ w_j^p to the denominator, with v_i the binary verification label, w_i the 1–5 harm potential, and p=2.426 chosen so a harm score of 5 accounts for about half the weight when harm levels are uniformly distributed. The decompose-then-verify architecture with separate harm scoring is the mechanism that makes the weighting possible; the paper contrasts it with verification-only and end-to-end baselines.

What would settle it

Re-run the meta-evaluation with p=1 (plain harm-weighted average) and with p fitted to maximise expert agreement; if the rank correlation at p=1 does not fall, or if a fitted p differs substantially from 2.426, then the specific risk-weighting mechanism is not what drives the reported agreement.

Watch

Extended reading notes

Core claim

The paper introduces a four-step pipeline: split an answer into citation segments; decompose each segment into atomic claims using an LLM with conversational context; score each claim twice—once for whether the cited excerpts support it (binary) and once for its harm potential on a 1–5 scale; then aggregate the two signals into a risk-adjusted verification score. The aggregation raises each harm score to a fixed exponent p=2.426 so that high-harm claims dominate the penalty, and reports the fraction of total weighted harm potential that remains unverified. The authors argue that this risk-weighting is what makes the score clinically informative, and they validate it by correlating both the c

Load-bearing premise

The load-bearing premise is that the hand-set exponent p=2.426, which makes a harm score of 5 carry about half of the total weight, captures how veterinarians actually trade off harm; the same exponent is used to build the human gold score that VetScore is measured against, so if that weighting is wrong, the combined-score validation weakens.

Editorial extensions

If this is right

  • An automated VetScore run can flag individual unverified high-harm claims (e.g. a wrong dose) in real time, giving practitioners a threshold-based safety filter rather than a single opaque number.
  • Deployment with open-weight models like Gemma 4 31B is viable, with only about 0.06 lower correlation than the best proprietary judge on the combined score.
  • Verification-only scoring without harm weighting loses alignment with expert absolute combined scores, so the risk-weighting component is doing measurable work.
  • End-to-end single-prompt scoring, without decomposition, correlates less than half as well with experts, showing the multi-step structure is necessary.
  • The component scores (verification, harm) each carry explainability as natural-language justifications, so the pipeline doubles as an audit trail.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • If the risk exponent were re-estimated on held-out expert data instead of being hand-set, the pipeline could adapt across specialties; testing a flat p would reveal whether the exact value matters.
  • Because the score only measures claims the system actually states, a model that omits a key warning could score well; explicit omission-aware penalties would close that gap.
  • The same harm-weighted decomposition could transfer to human medical QA, but the 1–5 rubric would need re-anchoring to human clinical decisions before use.
  • Comparing VetScore against a simple harm-weighted average (p=1) would isolate whether the concave weighting, rather than the decomposition, drives expert agreement.
Share X Bluesky LinkedIn Reddit HN

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

4 major / 5 minor

Summary. The paper presents VetScore, a decompose-then-verify evaluation method for veterinary long-form QA with citations. The pipeline segments a generated answer, decomposes each segment into atomic claims, verifies each claim against the cited excerpts, scores each claim for its potential clinical harm on a 1–5 scale, and aggregates the two signals into a risk-adjusted score using an exponent p=2.426 (Eqs. 1–4). The authors construct a meta-evaluation dataset from 67 queries, six generator LLMs, 1,200 cited segments, and 4,986 claims, annotated by 18 veterinary experts. They evaluate nine judge models and report Spearman correlations up to 0.783 for fact verification, 0.763 for harm potential, and 0.740 for the absolute combined score, with the open-weight Gemma 4 31B reaching 0.724/0.721/0.677. Ablations, IRT-based annotator adjustment, consistency analysis, and token-efficiency analysis are also included.

Significance. If the central claim holds, VetScore offers a clinically interpretable, explainable, and risk-aware faithfulness signal for a high-stakes domain, and the expert-annotated dataset is a useful resource for future work. The component-level results—fact verification and harm potential scoring—are the most robust part of the paper: they are evaluated against independent human annotations and show strong correlations across multiple judge models, including open-weight ones. The paper also deserves credit for its explicit ablation study, use of IRT to handle annotator severity, and systematic analysis of decomposition errors. However, the paper's headline risk-weighted combined score is currently under-supported because the human 'combined' gold is constructed using the same hand-set exponent p that defines the model score, and no sensitivity analysis or holistic expert validation is provided. This limits the strength of the conclusions that can be drawn from the combined-score columns.

major comments (4)
  1. [Section 3.2, Eqs. (1)–(4), Table 3] The combined-score validation is confounded by the shared hand-set exponent p. The paper fixes p=2.426 in footnote 2 and uses the same exponent to build both the model score and the human 'combined' gold against which the model is correlated. Since Spearman correlation is rank-based, any monotone transformation of the harm weights affects the model and human rankings in the same way. The reported combined correlations (e.g., 0.740 for Gemini 3.6 Flash, 0.677 for Gemma 4 31B) may therefore reflect agreement on the weighting convention rather than agreement on a clinically meaningful risk-adjusted verification score. The paper does not vary p, does not compare against p=1 or equal weighting, and does not elicit a harm-tradeoff weighting from experts. This is load-bearing because the risk-adjusted combined score is the paper's core contribution. Please add a sensitivity analysis over p and
  2. [Limitations, Section 5 (Meta-evaluation)] The manuscript explicitly states in the Limitations that holistic segment-level scores were not annotated. The human combined gold is constructed by applying the same aggregation equations (Eqs. 2–4) to component human scores. This makes the combined-score correlation partly circular: the model and the gold share the same nonlinear weighting assumption. The limitation is acknowledged, but it is not reflected in the abstract or conclusion, where the combined score is presented as a headline result. A subset of segments with holistic expert risk-adjusted ratings would break the circularity; at minimum, the claims in the abstract and Section 7 should be tempered to component-level validation unless such evidence is added.
  3. [Table 3, Verification-only rows] The claimed advantage of risk weighting is not visible in the normalized local and global combined scores. For Gemini 3.6 Flash, verification-only achieves rho=0.770 (local) and 0.788 (global), compared with VetScore's 0.760 and 0.772; the differences are small and sometimes in the opposite direction from the headline. The only column where risk weighting improves the correlation substantially is the absolute combined score (0.666 vs. 0.740 for Gemini 3.6 Flash). However, S_abs is unbounded and sensitive to segment length and claim count, so it is not a clean measure of risk-adjusted verification. The paper should either explain why the normalized scores are the appropriate metric despite showing no benefit from risk weighting, or restrict the risk-weighting claim to the absolute score with appropriate caveats.
  4. [Section 4.3, Task 2] The harm-potential annotation has only moderate inter-annotator agreement (Krippendorff's alpha=0.462). While the IRT-based adjustment in Appendix G is a reasonable and well-described remedy, the noise in the harm gold propagates into the combined gold and therefore into the combined-score correlations. This is acknowledged only implicitly. The combined correlations should be interpreted with this noise in mind, and the paper would be stronger if the sensitivity of the combined score to the harm-gold quality were analyzed, e.g., by recomputing the combined correlation under alternative aggregations of the raw harm annotations.
minor comments (5)
  1. [Eq. (1)] The notation in Eq. (1) reuses the index i for both the segment and the claims within the segment. Use a separate index (e.g., j) for claims to avoid confusion, consistent with the problem statement.
  2. [Appendix J.1] The text in Appendix J.1 swaps the references to Figure 15 and Figure 16. It states that Figure 16 shows human scores and Figure 15 shows LLM judge scores, but the figures are captioned the other way around.
  3. [Abstract / Section 4] The abstract says 'Code and data will be released' while the contributions list says 'We make our meta-evaluation dataset publicly available.' Please make the release status and timeline consistent, and note whether the annotation interfaces and model outputs will also be released.
  4. [Abstract] Minor grammar issue: 'how well are generated claims supported' should be 'how well generated claims are supported.'
  5. [Table 3] The table caption introduces 'Combined (local)' and 'Combined (global)' but the main text does not define which equations produce these variants. Please add a reference to Eqs. (2) and (3) in the caption or surrounding text.

Circularity Check

1 steps flagged · score 3.0 of 10

Combined-score validation is partly self-referential: the human combined gold is built with the same hand-set harm-weight exponent p=2.426 as VetScore; the component-level correlations are independently validated.

  1. self definitional [Section 3.2, Equations (1)-(4) and footnote 2; Section 5, Meta-evaluation; Limitations]
    ""The exponent p allows us to control the contribution of higher scores to the penalty relative to lower scores. We use p= 2.426 in all experiments." ... "We also evaluate combined scores obtained through the aggregation method (see Section 3.2) by calculating the Spearman correlation with combined scores derived from the human annotation.""

    The human 'combined' gold is not an independent holistic expert judgment; it is constructed by applying the same Section 3.2 aggregation (including the same hand-set p=2.426) to the human fact-verification and harm-potential labels. Therefore the Combined columns of Table 3 compare two applications of the same nonlinear weighting formula to different component scores. Any rank distortion caused by the exponent is applied on both sides, so the correlation cannot validate the risk-weighting choice itself. The Limitations section confirms that no holistic segment-level scores were annotated. The fact-verification and harm-potential component correlations are independent of this issue, since they use raw human labels.

full rationale

The paper's component-level claims are not circular: fact verification and harm potential scoring are each correlated with independently collected human annotations on those components (Spearman up to 0.783 and 0.763, respectively). Claim decomposition is manually validated with a separate error analysis. No load-bearing self-citation or imported uniqueness theorem is used; the OpeNLGauge citation is background only. The circularity concern is confined to the risk-weighted combined score. The human combined gold is 'derived from the human annotation' using 'the aggregation method (see Section 3.2)', i.e., the same hand-set p=2.426 that defines VetScore's combined score. Because the target is constructed from the same formula, the combined-score correlation measures agreement between two applications of that formula rather than validating the formula against an external holistic expert judgment. This is partial self-definitionality, not a full reduction: the model's component scores are genuinely independent predictions, and a different judge model could still rank segments differently. Still, the headline 'risk-adjusted score' correlation is weaker evidence than the component correlations, and the paper itself notes the absence of holistic segment-level annotation. Score 3 reflects one partially self-referential validation step while the central component evaluations retain independent content.

Assumptions & free parameters 1 free parameters · 5 assumptions · 0 invented entities

The central result rests on a small set of domain assumptions: that excerpt faithfulness is the right evaluation target, that expert annotations are a valid gold standard despite moderate agreement, that one fixed decomposition model is adequate, and that the hand-set weight exponent p=2.426 is clinically meaningful. No new physical or conceptual entities are introduced; the harm potential score is a rating scale, not an entity.

free parameters (1)
  • Harm weight exponent p = 2.426
    Hand-set in Equations (1)-(4) so a harm score of 5 carries 50% of total weight when harm levels are uniformly distributed. No sensitivity analysis; the same p is used to construct the human combined gold scores, so the risk-weighting claim is not independently tested.
assumptions (5)
  • domain assumption Faithfulness to the provided excerpts is the correct target for evaluating veterinary answers.
    The problem statement in Section 3.1 defines the task as excerpt-based faithfulness and leaves external fact-checking to future work.
  • domain assumption Veterinary expert annotations are a valid gold standard for verification and harm potential.
    Section 4.3: moderate inter-annotator agreement (alpha=0.462 harm, alpha=0.623 verification) is treated as acceptable after IRT adjustment.
  • domain assumption Claims generated by Gemini 3 Flash are the right unit for all subsequent evaluation.
    Section 4.4 manually validates only 120 of 1,200 segments; the pipeline is not tested with other decomposers.
  • ad hoc to paper p=2.426 yields clinically meaningful risk weights.
    Footnote 2: chosen so score-5 claims carry half the weight under equal representation; no external validation.
  • standard math The IRT partial credit model assumptions hold for annotator aggregation.
    Appendix G fits the PCM and reports fit statistics as reasonable, but the model's validity is a statistical assumption.

how reviews work

0 comments
Cite this review

Pith. "Pith review of VetScore: Risk-Weighted Fact Verification for Veterinary Long-Form QA with Citations." pith.science (2026). https://pith.science/paper/IYD6OFGJ

@misc{pith2026260803675,
  author       = {Pith},
  title        = {Pith review of: VetScore: Risk-Weighted Fact Verification for Veterinary Long-Form QA with Citations},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/IYD6OFGJ}},
  note         = {Machine review of arXiv:2608.03675}
}
read the original abstract

Citation excerpts can be used to increase the reliability of generated outputs and their faithfulness to cited sources, which is especially important in high-stakes domains such as human and veterinary medicine. However, this does not guarantee that generated claims are faithful to the provided excerpts. We present VetScore, a multi-step evaluation method for veterinary long-form question answering, designed to assess how well are generated claims supported by the provided excerpts, weighing this information by each claim's harm potential. VetScore first segments the output and decomposes it into individual claims, then scores each claim with respect to its harm potential and evaluates its faithfulness to source excerpts, and finally calculates the overall risk-adjusted score. We collect an expert-annotated meta-evaluation dataset, evaluate our approach with a range of judge models, and show that it achieves high correlations with veterinary experts even with small judge models, while offering explainability across multiple dimensions.

Figures

Figures reproduced from arXiv: 2608.03675 by the authors.

Figure 1
Figure 1. Overview of the VETSCORE pipeline. 1 Claim decomposition splits a segment of the output to atomic claims, 2 Harm potential scoring assigns a score (1-5) to each claim, indicating the potential harm of the claim, 3 Fact verification decides for each claim whether it is supported by the given source excerpt(s), and 4 Combined score aggregates verification and harm potential scores to a final score for the segment. cit… view at source ↗
Figure 2
Figure 2. Prompt template for claim decomposition. [PITH_FULL_IMAGE:figures/full_fig_p018_2.png] view at source ↗
Figure 3
Figure 3. Prompt template for claim verification. 18 [PITH_FULL_IMAGE:figures/full_fig_p018_3.png] view at source ↗
Figures from the paper (16 more)
Figure 4
Figure 4. Figure 4: Prompt template for harm potential scoring. [PITH_FULL_IMAGE:figures/full_fig_p019_4.png]
Figure 5
Figure 5. Figure 5: System prompt template for relevance assessment of retrieved sources. [PITH_FULL_IMAGE:figures/full_fig_p020_5.png]
Figure 6
Figure 6. Figure 6: System prompt template for output generation. [PITH_FULL_IMAGE:figures/full_fig_p020_6.png]
Figure 7
Figure 7. Figure 7: User prompt template for output generation. [PITH_FULL_IMAGE:figures/full_fig_p021_7.png]
Figure 8
Figure 8. Figure 8: Distribution of disciplines, question types, and patient species represented our input queries. [PITH_FULL_IMAGE:figures/full_fig_p021_8.png]
Figure 9
Figure 9. Figure 9: Distribution of citation excerpt lengths for the six LLMs across the 67 queries. Boxes show the inter [PITH_FULL_IMAGE:figures/full_fig_p025_9.png]
Figure 10
Figure 10. Figure 10: Mean pairwise inter-annotator agreement (Krippendorf’s [PITH_FULL_IMAGE:figures/full_fig_p025_10.png]
Figure 11
Figure 11. Figure 11: The annotation interface for the fact verification task. [PITH_FULL_IMAGE:figures/full_fig_p026_11.png]
Figure 12
Figure 12. Figure 12: The annotation interface for the harm potential scoring task. [PITH_FULL_IMAGE:figures/full_fig_p027_12.png]
Figure 13
Figure 13. Figure 13: Wright map for out PCM model. Left: Latent harm potential distribution of annotated claims. Right: Annotator harm sensitivity (severity) and effective thresholds. Each thresholds shows a location on the latent harm potential axis where the probability of two adjacent …
Figure 14
Figure 14. Figure 14: Infit and outfit mean square statistics for our PCM model. The lighter band shows the threshold band [PITH_FULL_IMAGE:figures/full_fig_p032_14.png]
Figure 15
Figure 15. Figure 15: Distribution of human annotation scores for both tasks. [PITH_FULL_IMAGE:figures/full_fig_p032_15.png]
Figure 16
Figure 16. Figure 16: Distribution of judge model scores for the [PITH_FULL_IMAGE:figures/full_fig_p034_16.png]
Figure 17
Figure 17. Figure 17: Distribution of judge model scores for the [PITH_FULL_IMAGE:figures/full_fig_p035_17.png]
Figure 18
Figure 18. Figure 18: Variance of scores across runs. Verification flip rate is the average percentage of flipped verification scores within a sample. Scoring sample std shows the standard deviation of the sample scores. 35 [PITH_FULL_IMAGE:figures/full_fig_p035_18.png]
Figure 19
Figure 19. Figure 19: Average output tokens per segment. Boxes show the inter-quartile range (IQR), whiskers extend to [PITH_FULL_IMAGE:figures/full_fig_p036_19.png]

Discussion (0). Continue with ORCID to comment.

Reference graph

Works this paper leans on

75 extracted references · 70 canonical work pages

  1. [2]

    Provide a brief explanation (1-3 sentences) of why the claim is supported or not

    work page

  2. [3]

    Return true if the claim can be found or reasonably inferred from any source

    work page

  3. [4]

    claim":

    Return false if the claim contradicts sources or cannot be verified OUTPUT FORMAT (array of objects): [ { "claim": "<verbatim copy of claim>", "reasoning": "<explanation>", "isSupported": true/false }, ... ] IMPORTANT: Return exactly {n_claims} objects in the array, one for each fact in the same order. Figure 3: Prompt template for claim verification. 18 ...

    work page

  4. [5]

    The dosage is 10mg per kg orally twice daily for 7 days

    Make sure to support all your factual claims by citations with excerpts. EXAMPLES: "The dosage is 10mg per kg orally twice daily for 7 days."["recommended daily dose of 10mg/kg of body weight, PO, q12h for the duration of seven days"](journal_abc12345:L45-46) "Symptoms include diarrhea, vomiting, and lethargy."["Vomiting, diarrhea, and lethargy"] (journal...

    work page 2026

  5. [6]

    CoRR, abs/2605.06635

    Cited but not verified: Parsing and evaluat- ing source attribution in LLM deep research agents. CoRR, abs/2605.06635. Qwen Team. 2026. Qwen3.5: Towards native multi- modal agents. Hannah Rashkin, Vitaly Nikolaev, Matthew Lamm, Lora Aroyo, Michael Collins, Dipanjan Das, Slav Petrov, Gaurav Singh Tomar, Iulia Turc, and David Reitter. 2023. Measuring attrib...

    arXiv 2026

  6. [7]

    Attribution, citation, and quotation: A sur- vey of evidence-based text generation with large lan- guage models. InProceedings of the 64th Annual Meeting of the Association for Computational Lin- guistics (Volume 1: Long Papers), ACL 2026, pages 30956–31000, San Diego, California, United States. 11 Meet Shah, Jason Gusdorf, Anil Palepu, Chunjong Park, Jac...

    work page Pith review arXiv 2026

  7. [8]

    InAdvances in Neural Information Processing Sys- tems 37: Annual Conference on Neural Information Processing Systems 2024, NeurIPS 2024, Vancouver, BC, Canada

    Long-form factuality in large language models. InAdvances in Neural Information Processing Sys- tems 37: Annual Conference on Neural Information Processing Systems 2024, NeurIPS 2024, Vancouver, BC, Canada. Claire E Welsh, Marco Duz, Timothy DH Parkin, and John F Marshall. 2017. Disease and pharmaco- logic risk factors for first and subsequent episodes of...

    work page 2024

  8. [9]

    The required dose of propofol for induction in the trazodone group was 1.36±0.55 mg/kg

    work page

Show all 75 references
  1. [10]

    The required dose of propofol for induction in the placebo group was 2.13±1.20 mg/kg

  2. [11]

    The reduction in propofol dose for induction was not statistically signifi- cant

  3. [12]

    enriched with 6.5 per cent MCT oil (as fed basis)

    The study results showed a trend toward lower propofol doses in the tra- zodone group. Suboptimal decomposition The attributes of the study (prospec- tive, randomized, double-blinded, in- volving 16 dogs) should each have a corresponding atomic claim. Efficacy has been demonst...

  4. [14]

    Copy the claim verbatim (exact text)

  5. [15]

    Provide a brief explanation (1–3 sentences) of the score

  6. [16]

    claim":

    Assign a score based on the rubric above (1–5) FACTS TO SCORE: {claims} OUTPUT FORMAT (JSON array): [ { "claim": "<verbatim copy of claim>", "reasoning": "<explanation>", "score": <1-5> }, ... ] Return exactly {num_claims} objects, one for each fact in order. Figure 4: Prompt ...

  7. [17]

    EVERY factual statement MUST have a citation immediately after it

  8. [18]

    Quote excerpt text from the source that supports the claim

  9. [19]

    Use ONLY source IDs from the provided source list

  10. [20]

    Factual claim

    Multiple sources for the same fact use SEPARATE brackets: "Factual claim"["excerpt A"](source1)["excerpt B"](source2)

  11. [22]

    Studies have evaluated the admin- istration of robenacoxib at extreme dosages

  12. [23]

    One extreme dosage studied was 20 times the recommended dose of robe- nacoxib

  13. [24]

    The duration of the extreme dosage study was 42 days

  14. [25]

    The extreme dosage was admin- istered at 10 mg/kg every 12 hours (q12h)

  15. [26]

    Suboptimal decomposition Claim (4) contains both a dose and frequency claims

    The administration of robenacoxib at 20 times the recommended dose for 42 days resulted in no observable toxic effects. Suboptimal decomposition Claim (4) contains both a dose and frequency claims. These should be de- composed into two separate claims for the system to be able...

  16. [27]

    A prospective, randomized, double-blinded clinical study was conducted involving 16 female dogs undergoing ovariectomy

  17. [28]

    Trazodone was administered at a dose of 5 mg/kg orally

  18. [29]

    Trazodone was administered 2 hours prior to hospital arrival

  19. [30]

    Trazodone significantly reduced stress scores on the Clinic Dog Stress Scale (CDSS) compared to placebo

  20. [31]

    The mean CDSS score for the tra- zodone group was 5.12±2.95

  21. [32]

    The mean CDSS score for the placebo group was 11.50±6.16

  22. [33]

    The p-value for the difference in CDSS scores was 0.02

  23. [34]

    Trazodone reduced the required doses of propofol for induction com- pared to placebo

  24. [39]

    Efficacy has been demonstrated in trials evaluating diets enriched with MCT oil

  25. [40]

    The diets evaluated in these trials were enriched with 6.5% MCT oil

  26. [41]

    Suboptimal decomposition The claim could be further decom- posed to two separate claims: one about the trials and the other about their efficacy

    The 6.5% MCT oil enrichment level is calculated on an as-fed basis. Suboptimal decomposition The claim could be further decom- posed to two separate claims: one about the trials and the other about their efficacy. Continued on next page 28 Table 7 – continued from previous pag...

  27. [42]

    Further research on maropitant is required

  28. [43]

    The literature concludes that stud- ies investigating the pharmacokinetics of maropitant in other species are war- ranted

  29. [44]

    The literature concludes that pharmacodynamic studies evaluat- ing the potential for maropitant’s use as an anti-inflammatory drug in birds are warranted

  30. [45]

    Semantic drift Coordination scope error

    The literature concludes that the performance of pharmacodynamic studies for maropitant in birds is warranted. Semantic drift Coordination scope error. The combination of advanced age and a structural brain lesion signifies a higher risk of early mortality

  31. [46]

    Advanced age signifies a higher risk of early mortality

  32. [47]

    A structural brain lesion signifies a higher risk of early mortality

  33. [48]

    Semantic drift Fallacy of division: the original claim links the risk to the combination of the two factors, not to any of the factors in isolation

    The combination of advanced age and a structural brain lesion signifies a higher risk of early mortality. Semantic drift Fallacy of division: the original claim links the risk to the combination of the two factors, not to any of the factors in isolation. Dogs with no antimicro...

  34. [49]

    Dogs that received no antimicro- bials had a median hospitalization of 1 day

  35. [50]

    Dogs that received no antimicro- bials showed significant improvement after fluid resuscitation

  36. [51]

    Semantic drift Missing evidential link between the first two claims and the last claim

    Supportive care is sufficient in most cases of AHDS. Semantic drift Missing evidential link between the first two claims and the last claim. The **most defensible evidence- based position** is that ponazuril is a biologically credible option be- cause it is toltrazuril’s main ...

  37. [52]

    The most defensible evidence- based position is that ponazuril is a biologically credible option

  38. [53]

    Ponazuril is the main metabolite of toltrazuril

  39. [54]

    Ponazuril has pharmacokinetic fea- tures compatible with durable anticoc- cidial activity

  40. [55]

    Toltrazuril has broad evidence of efficacy in species other than dogs

  41. [56]

    Toltrazuril has known limitations related to the timing of treatment

  42. [57]

    Semantic drift Missing causal link between claim (1) and claims (2) and (3)

    Toltrazuril has known limitations related to possible resistance. Semantic drift Missing causal link between claim (1) and claims (2) and (3). The current evidence supporting the use of low-dose ketamine specifi- cally for the medical management of abdominal pain (colic) in ho...

  43. [58]

    Low-dose ketamine is used for the medical management of abdominal pain in horses

  44. [59]

    Abdominal pain in horses is also known as colic

  45. [60]

    The current evidence supporting the use of low-dose ketamine for the med- ical management of abdominal pain in horses is limited

  46. [61]

    current evi- dence supporting the use of low-dose ketamine is limited

    Non-steroidal anti-inflammatory drugs (NSAIDs) are the standard of care for the medical management of abdominal pain in horses. Semantic drift A presupposition is incorrectly inter- preted as an entailment: “current evi- dence supporting the use of low-dose ketamine is limited...

  47. [62]

    Evidence regarding trazodone use in this scenario must be extrap- olated from studies in non-pregnant dogs undergoing surgery

  48. [63]

    Studies in non-pregnant dogs under- going surgery suggest trazodone can reduce pre-surgical stress

  49. [64]

    this scenario

    Studies in non-pregnant dogs under- going surgery suggest trazodone can reduce anesthetic requirements. Decontextualization The anaphora (“this scenario”) is not resolved properly. The same cohort reported that ivabradine was discontinued in 4 of 7 SVT patients after resolutio...

  50. [65]

    The same cohort reported that ivabradine was discontinued in 4 of 7 SVT patients

  51. [66]

    The discontinuation of ivabra- dine occurred after resolution of tach- yarrhythmia

  52. [67]

    The discontinuation of ivabradine occurred after improvement in heart rate

  53. [68]

    The findings support the short-term effectiveness of ivabradine in selected infants

  54. [69]

    The findings support the medium- term effectiveness of ivabradine in se- lected infants

  55. [70]

    the same cohort

    The findings do not specifically prove superiority of the beta-blocker combination over other regimens. Decontextualization The anaphora (“the same cohort”) is not resolved properly. As of 2026, the most current and high-certainty evidence indicates that **continuous or prolon...

    2026

  56. [71]

    As of 2026, the evidence for beta- lactam infusion in dogs with sepsis is the most current

    2026

  57. [72]

    The evidence supporting the rec- ommendations is of high certainty

  58. [73]

    Continuous infusion of beta-lactam antibiotics is recommended for dogs with sepsis

  59. [74]

    Prolonged infusion of beta-lactam antibiotics is recommended for dogs with sepsis

  60. [75]

    The recommendation for contin- uous or prolonged infusion applies when pharmacodynamic targets are difficult to achieve with intermittent dosing

  61. [76]

    Uninformative The claims are not informative, since the first claim is tautological, while the second claim is unverifiable

    The pharmacodynamic target for beta-lactam antibiotics is time above MIC (minimum inhibitory concentra- tion). Uninformative The claims are not informative, since the first claim is tautological, while the second claim is unverifiable. 30 # Original Fixed∆ 1 1.000 0.733 -0.267...

    1994

  62. [2016]

    Evaluation of supervised machine-learning al- gorithms to distinguish between inflammatory bowel 9 disease and alimentary lymphoma in cats.Journal of veterinary diagnostic investigation, 28(6):679–687. Mayla R. Boguslav, Adam Kiehl, David Kott, G. Joseph Strecker, Tracy Webb, ...

    2024 arXiv

  63. [2022]

    Sewon Min, Kalpesh Krishna, Xinxi Lyu, Mike Lewis, Wen tau Yih, Pang Wei Koh, Mohit Iyyer, Luke Zettlemoyer, and Hannaneh Hajishirzi

    Teaching language models to support answers with verified quotes.CoRR, abs/2203.11147. Sewon Min, Kalpesh Krishna, Xinxi Lyu, Mike Lewis, Wen tau Yih, Pang Wei Koh, Mohit Iyyer, Luke Zettlemoyer, and Hannaneh Hajishirzi. 2023. FActScore: Fine-grained atomic evaluation of factu...

    2023 arXiv

  64. [2023]

    InProceedings of the 2023 Con- ference on Empirical Methods in Natural Language Processing, EMNLP 2023, pages 6465–6488, Singa- pore

    Enabling large language models to generate text with citations. InProceedings of the 2023 Con- ference on Empirical Methods in Natural Language Processing, EMNLP 2023, pages 6465–6488, Singa- pore. Anisha Gunjal and Greg Durrett. 2024. Molecular facts: Desiderata for decontext...

    2023

  65. [2024]

    InFindings of the Association for Computational Linguistics, ACL 2024, volume ACL 2024 ofFindings of ACL, pages 14095–14113, Bangkok, Thailand

    Learning fine-grained grounded citations for attributed large language models. InFindings of the Association for Computational Linguistics, ACL 2024, volume ACL 2024 ofFindings of ACL, pages 14095–14113, Bangkok, Thailand. Brian Hur, Timothy Baldwin, Karin Verspoor, Laura Hard...

    2024 arXiv

  66. [2025]

    Context-dependent scoring

    First, do NOHARM: Towards clinically safe large language models.CoRR, abs/2512.01241. Judit M. Wulcan, Kevin L. Jacques, Mary Ann Lee, Samantha L. Kovacs, Nicole Dausend, Lauren E. Prince, Jonatan Wulcan, Sina Marsilio, and Stefan M. Keller. 2024. Classification performance an...

    2024 arXiv

  67. [2026]

    E70052 VOP-25-04- 3534

    Comparison of diagnostic performance be- tween large language models and veterinary evalua- tors in feline ocular diseases based on clinical sum- maries and anterior segment photographs.Veterinary Ophthalmology, 29(1):e70052. E70052 VOP-25-04- 3534. Hailey Onweller, Elias Lume...

Pith tools

Reviewed August 5, 2026 · model on record in the stance chip above.